I-ELCAP Moves From Weill Cornell To Arizona State

From The Cancer Letter, Jan. 22, 2010:

A controversial program aimed at screening current and former smokers for signs of early-stage lung cancer is in the process of departing from Weill Cornell Medical College.

The research group, called the International Early Lung Cancer Action Program, said it has moved its “coordinating site” to the Arizona State University’s Biodesign Institute in Tempe, and top academic leaders of the group now appear on the web site of Mount Sinai School of Medicine.

I-ELCAP, led by radiologist Claudia Henschke, has been plagued with problems, which included revelations of undisclosed conflicts of interest, receiving funding from a tobacco company, and retractions of key scientific claims about effectiveness of screening for early lung cancer.

Also in this issue:

• Ratain To Lead New Center For Personalized Therapeutics At University of Chicago
  

For the rest of the story, click on The Cancer Letter Archive at left to read the Jan. 15 issue (subscription or day pass required).

The Cancer Letter is no longer offered in a print edition. Former print subscribers: if you haven't already given us your email address, please use the Contact Us link at left.
_____
tags: cancer screening